Tang Milling, Chairman of Zixi Palace: The Beijing Stock Exchange adheres to the positioning of serving small and medium-sized enterprises and will promote "double creation"

Per reporter: Wang Jing Per editor: Chen Junjie

As one of the first listed companies to land on the Beijing Stock Exchange, Ziqigong (832566, BJ) is a national high-tech enterprise focusing on drug research and development, production and marketing, through years of continuous investment, the company has developed a number of new drugs such as citicoline sodium tablets, rizatriptan benzoate capsules and so on. At the same time, the company is also a "Chinese time-honored brand" enterprise, but in 2003, Ziqi Palace encountered debt problems, the company's core product formula was taken away by other companies, how to revive the "Chinese time-honored brand" is the problem faced by chairman Tang Milling.

Courtesy of respondents

On December 20, the 10th China Listed Companies Summit Forum Week 2021 hosted by the Daily Economic News kicked off with the theme of "Scientific and Technological Innovation and Green Development". At the 2021 China "Specialized, Specialized and New" Enterprise Development Forum held on the morning of December 21, Tang Milling shared his thoughts with the outside world and made a keynote speech on "The Road to the Rejuvenation of "China's Time-honored Brands": How to Stimulate the Innovation Vitality and Growth Momentum of Enterprises".

Tang Milling said that innovation is an eternal topic, and innovation is also very difficult, especially in the pharmaceutical industry where the company is located, there is no 10 years to develop a new drug, and it is very difficult to have no actual investment. However, with such a good platform as the Beijing Stock Exchange, I believe that the situation of difficult innovation will continue to change.

Founded during the Qianlong period of the Qing Dynasty, the "ZiQigong" brand is one of the oldest pharmaceutical brands in Sichuan Province, but due to poor management, Ziqigong faced closure in 2003. At that time, Tang Milling, who had been working in shanghai for many years, was already a returnee doctor with little success. The determination of the Neijiang Municipal Party Committee and the Neijiang Municipal Government to revitalize the "century-old brand" touched dr. Tang Milling, a returnee, who gave up his high-paying job in Shanghai and came to Neijiang to start a business.

In the past 18 years, through research and development, production and marketing, Zixi Palace has developed from no products to an annual operating income of more than 300 million yuan and a net profit of nearly 60 million yuan. For the main source of the core competitiveness of enterprises, Tang Milling summarized as: "People have no me, people have me excellent." ”

He believes that if ordered by competitiveness, "specialized and specialized" should be specialized, new, refined, and special. Among them, "special" refers to focusing on a certain field to develop; "fine" refers to excellence and achieve the ultimate; "special" means to have key and unique products and services or technologies; "new" refers to innovation.

In Tang Milling's view, the establishment of the Beijing Stock Exchange is a gift to small and medium-sized enterprises. "The Beijing Stock Exchange mainly targets 'specialized, specialized and new' enterprises, helping those enterprises that have initial development but are not big enough to accelerate their growth. The Beijing Stock Exchange gives specialized new companies the opportunity to directly raise funds when they need help most in the process of entrepreneurial growth. Ziqi Palace became one of the first listed companies after the establishment of the Beijing Stock Exchange, which is the company's luck. ”

In recent years, Ziqigong has continued to increase investment in research and development, and has developed a number of new drug varieties such as citicoline sodium tablets, rizatriptan benzoate capsules, and actively cooperated with many colleges and universities and research institutes to establish a new drug innovation research and development platform.

In Tang Milling's view, "the Beijing Stock Exchange adheres to the positioning of serving the innovative small and medium-sized enterprise market, will further promote mass entrepreneurship and innovation, and hopes that more entrepreneurs and innovators can join the national strategy of scientific and technological power and industrial rejuvenation in the future." ”

Daily economic news